Redox Limited Recorded A 5.9% Miss On Revenue: Analysts Are Revisiting Their Models

Last week, you might have seen that Redox Limited (ASX:RDX) released its yearly result to the market. The early response was not positive, with shares down 7.1% to AU$3.01 in the past week. Revenues came in 5.9% below expectations, at AU$1.1b. Statutory earnings per share were relatively better off, with a per-share profit of AU$0.17 being roughly in line with analyst estimates. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

See our latest analysis for Redox

Taking into account the latest results, the current consensus from Redox's dual analysts is for revenues of AU$1.24b in 2025. This would reflect a decent 9.2% increase on its revenue over the past 12 months. Before this earnings report, the analysts had been forecasting revenues of AU$1.36b and earnings per share (EPS) of AU$0.19 in 2025. So we can see that while the consensus made a small dip in revenue estimates, it no longer provides an earnings per share estimate. This suggests that the market is now more focused on revenue after the latest result.

There's been no real change to the consensus price target of AU$3.24, with Redox seemingly executing in line with expectations.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We can infer from the latest estimates that forecasts expect a continuation of Redox'shistorical trends, as the 9.2% annualised revenue growth to the end of 2025 is roughly in line with the 11% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 5.5% per year. So it's pretty clear that Redox is forecast to grow substantially faster than its industry.

The Bottom Line

The clear low-light was that the analysts cut their forecast revenue estimates for Redox next year. Regrettably, they also downgraded their revenue estimates, but the latest forecasts still imply the business will grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

We have estimates for Redox from its dual analysts out to 2027, and you can see them free on our platform here.

And what about risks? Every company has them, and we've spotted 1 warning sign for Redox you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.